Implantable Cardiac Monitors Market is segmented By Application (Arrhythmia, Atrial Fibrillation, Others), By End-User (Hospitals & Clinics, Home Sett....
Market Size in USD
CAGR5.13%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.13% |
Market Concentration | High |
Major Players | Medtronic, Abbott, BioTelemetry, Boston Scientific Corporation, Biotronik SE & Co. KG |
The implantable cardiac monitors market is estimated to be valued at USD 1.1 Bn in 2024 and is expected to reach USD 1.6 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.13% from 2024 to 2031. The increasing incidence of cardiac arrhythmias and the rising importance of remote monitoring for such patients is expected to drive the demand for implantable cardiac monitors in the forecast period.
The implantable cardiac monitors market is expected to witness significant growth owing to the rising geriatric population who are more prone to develop cardiac arrhythmias. Additionally, the growing awareness regarding benefits of long term cardiac monitoring and availability of reimbursements are factors anticipated to boost the market. However, issues related to device recalls and lengthy approval timelines may hamper market growth.